Evidence map›Paper›PMID 26511327›Full record

ArticleJournal of neuroinflammation2015

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.

Sevasti Flytzani, Andre Ortlieb Guerreiro-Cacais, Marie N'diaye, Maren Lindner, Christopher Linington, Edgar Meinl, Pernilla Stridh, Maja Jagodic, Tomas Olsson

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Sevasti FlytzaniCenter for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:04, Stockholm, Sweden. Sevasti.Flytzani@ki.se.
Andre Ortlieb Guerreiro-CacaisCenter for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:04, Stockholm, Sweden. Andre.Ortlieb@ki.se.
Marie N'diayeCenter for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:04, Stockholm, Sweden. Marie.N.Diaye@ki.se.
Maren LindnerInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Maren.Lindner@glasgow.ac.uk.
Christopher LiningtonInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Christopher.Linington@glasgow.ac.uk.
Edgar MeinlInstitute of Clinical Neuroimmunology, Ludwig-Maximilians-Universität, Munich, Germany. Edgar.Meinl@med.uni-muenchen.de.
Pernilla StridhCenter for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:04, Stockholm, Sweden. Pernilla.Strid@ki.se.
Maja JagodicCenter for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:04, Stockholm, Sweden. Maja.Jagodic@ki.se.
Tomas OlssonCenter for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, CMM L8:04, Stockholm, Sweden. Tomas.Olsson@ki.se.
Karolinska Institutet · SEUniversity of Glasgow · GBLudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundΙn multiple sclerosis (MS), axonal damage leads to permanent neurological disabilities and the spreading of the autoimmune response to axonal antigens is implicated in disease progression. Experimental autoimmune encephalomyelitis (EAE) provides an animal model that mimics MS. Using different EAE models, we investigated the pathophysiological basis of epitope spreading to neurofascin, a protein localized at the node of Ranvier and its regulation by non-MHC genes.

methodsWe used two different EAE models in DA rat; one which is induced with myelin oligodendrocyte glycoprotein (MOG) which leads to disease characterized by profound demyelination, and the second which is induced with myelin basic protein (MBP) peptide 63-88 which results in severe central nervous system (CNS) inflammation but little or no demyelination. We determined anti-neurofascin antibody levels during the course of disease. Furthermore, the anti-neurofascin IgG response was correlated with clinical parameters in 333 (DAxPVG.1AV1) x DA rats on which we performed linkage analysis to determine if epitope spreading to neurofascin was affected by non-MHC genes.

resultsSpreading of the antibody response to neurofascin occurred in demyelinating MOG-induced EAE but not in EAE induced with MBP peptide 63-88. Anti-neurofascin IgG levels correlated with disease severity in (DAxPVG.1AV1) x DA rats, and a genomic region on chromosome 3 was found to influence this response.

conclusionsInter-molecular epitope spreading to neurofascin correlates with disease severity in MOG-EAE is dependent on extensive demyelination and is influenced by non-MHC genes. The findings presented here may shed light on factors involved in the severity of MS and its genetics.

Indexed as

AnimalsCell Adhesion MoleculesDemyelinating DiseasesEncephalomyelitis, Autoimmune, ExperimentalEpitopesFemaleImmunoglobulin GInflammationMaleMyelin Basic ProteinMyelin-Oligodendrocyte GlycoproteinNerve Growth FactorsPeptidesRatsCell Adhesion MoleculesEpitopesImmunoglobulin GMyelin Basic ProteinMyelin-Oligodendrocyte GlycoproteinNerve Growth FactorsNfasc protein, ratPeptides

Identifiers

PMID26511327
PMCPMC4625640
OpenAlexW1821652572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.